POLYSUBSTANCE DRUG USE (INDISCRIMINATE DRUG USE)
Clinical trials for POLYSUBSTANCE DRUG USE (INDISCRIMINATE DRUG USE) explained in plain language.
Never miss a new study
Get alerted when new POLYSUBSTANCE DRUG USE (INDISCRIMINATE DRUG USE) trials appear
Sign up with your email to follow new studies for POLYSUBSTANCE DRUG USE (INDISCRIMINATE DRUG USE), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New program aims to keep hospital patients on track for opioid and meth recovery
Disease control OngoingThis study tests a program called MIAPP that helps people who use both opioids and methamphetamine stay connected to treatment after leaving the hospital. Participants receive a patient navigator, a smartphone app for medication check-ins, and small rewards for sticking with thei…
Matched conditions: POLYSUBSTANCE DRUG USE (INDISCRIMINATE DRUG USE)
Phase: NA • Sponsor: University of Washington • Aim: Disease control
Last updated May 13, 2026 15:58 UTC
-
Can a Parent-Peer program help young adults beat polysubstance use?
Knowledge-focused OngoingThis study tests a program called Launch for young adults (ages 18-26) who misuse multiple drugs and their supportive parent. The program provides peer recovery support to the young adult and helps parents use a reward-based system at home. The main goal is to see if the program …
Matched conditions: POLYSUBSTANCE DRUG USE (INDISCRIMINATE DRUG USE)
Phase: NA • Sponsor: Chestnut Health Systems • Aim: Knowledge-focused
Last updated May 15, 2026 11:55 UTC